Primary Central Nervous System Lymphomas in the Neurological Practice

V. I. Ponomaryov V. N. Karazin Kharkiv National University
O. Yu. Merkulova V. N. Karazin Kharkiv National University
V. A. Florikyan Kharkiv Medical Academy of Postgraduate Education
V. N. Ivasenko Medical service Southern Railway

Abstract

Primary central nervous system lymphoma is one of the rare tumors of nervous system. Brain lymphoma is a malignancy diseases with peculiar clinical and biologic features, aggressive course, and unsatisfactory outcome. Early diagnostic and adequate treatment can improve the outcome and prognosis of patients.

Downloads

Download data is not yet available.

References

Крячок И. А. Первичные лимфомы ЦНС: от науч-ных исследований к практике [Текст] / И. А. Крячок, Е. С. Филоненко, Е. В. Кущевой и др. // Клиническая онкология. – 2012. – 6 (2): 91–100.

De Angelis L. Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma [Text] / L. De Angelis, W. Seiferheld, S. Cliff ord Schold, B. Fisher and C. J. Schultz // Radiation Therapy Oncology Group Study 93–10. J Clin Oncol. – 1992. – Apr.; 10 (4): 635–43.

Corboy J. R. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS [Text] / J. R. Corboy // Garl Kleinschmidt-DeMasters BK Neurology. – Feb. 1998; No 50 (2): 335–40. [Medline]

Ferreri A. J. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. [Text] / A. J. Ferreri, M. Reni, M. Foppoli, et al. – Lancet, 2009; No 374 (9700): 1512–1520.

Ferreri A. J. How I treat primary CNS lymphoma [Text] / A. J. Ferreri // BLOOD. 21 July, 2011. Vol. 118, No 3. – P. 510–522.

Ferreri A. J. Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination [Text] / A. J. Ferreri, G. Licata, M. Foppoli, et al. // Oncologist. – 2011; No 16 (3): 336–341

Fischer L., Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients [Text] / L. Fischer, P. Martus, M. Weller et al. // Neurology. – Sep., 30, 2008; No 71 (14): 1102–8. [Medline]

Glass J. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome [Text] / J. Glass, M. L. Gruber, L. Cher, F. H. Hochberg // Journal of Neurosurgery. – Aug., 1994, No 81 (2): 188–195.

Gomez-Brouchet A. Delisle MB, Vital A, Brousset P. Immunohistochemical assessment of human herpesvirus 8 infection in primary central nervous system large B cell lymphomas[Text] / A. Gomez-Brouchet, M.B. Delisle, A. Vital, P. Brousset. //J Clin Pathol. – Aug., 2001; 54 (8): 617–8. [Medline]

Hottinger A. F. YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma [Текст] / A. F. Hottinger, F. M. Iwamoto, S. Karimi, et al. // Annals of Neurology. – Jan., 10, 2011.

Khong P. Isolated neurolymphomatosis of the cauda equina and fi lum terminale: case report. [Text] P. Khong, T. Pitham, B. Owler. // Spine. – Oct. 1, 2008; 33 (21): E807–11. [Medline]

Kiewe P. High-dose methotrexate is benefi cial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma [Text] / P. Kiewe, C. Loddenkemper, I. Anagnostopoulos // Neuro Oncol. – Apr. 2007., 9 (2): 96-102.

Lenarz M. Primary central nervous system lymphoma presenting as bilateral tumors of the internal auditory canal [Text] / M. Lenarz, М. Durisin, H. Becker, Т. Lenarz // Nejadkazem M. Skull Base. Nov. 2007. 17 (6): 409–12. [Medline]

Levin N. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis [Text] / N. Levin, D. Soff er, S. Grissaru, et al. // Neurooncol. Oct. 2008. 90 (1): 77–83. [Medline]

Linnebank M. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma [Text] / M. Linnebank, S. Schmidt, H. Kolsch et al. // Br. J. Cancer. – May, 17, 2004; 90 (10): 1969–71. [Medline]

Merritt’s Neurology 10th Edition (June 2000): by H. Houston Textbook of Neurology. / Merritt (Editor), L. P. Rowland (Editor), R. Rowland By Lippincott Williams & Wilkins Publishers. – Lymphomas: – P. 266–270.

Miller D. C. Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. [Text] / D. C. Miller, F. H. Hochberg, N. L. Harris et al. // The Massachusetts General Hospital experience – 1958–1989. – Cancer. – Aug. 15, 1994; 74 (4): 1383–97. [Medline]

Montesinos-Rongen M. Absence of immuno-globulin class isn’t show in primary lymphomas of the central nervous system [Text] / M. Montesinos-Rongen, R. Schmitz, C. Courts, et al // Am. J. Pathol. Jun. 2005; 166 (6): 1773–9. [Medline]

Neuwelt E. A., Goldman D. L., Dahlborg S. A., Crossen J., Ramsey F., Roman-Goldstein S., Braziel R., B. J. Dana, P. Clin. Oncol. Sep. 1991; 9 (9): 1580–90 Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

Grisariu S. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. [Text] / S. Grisariu, B. Avni, T. T. Batchelor, M. J. van den Bent, F. Bokstein, D. Schiff , O. Kuittinen, M. C. Chamberlain, P. Roth, A. Nemets, E. Shalom, D. Ben-Yehuda, T. Siegal // Blood. – 2010; 115(24): 5005–5011.

Sugita Y. SHP–1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients refl ects maturation stage of normal B cell counterparts [Text] / Y. Sugita, O. Tokunaga, A. Nakashima, M. Shigemori // Pathol Int. – Sep. 2004; 54 (9): 659–66. [Medline]

Taracads R. Primary CNS Lymphoma. Overview. [Electronic resource] / R. Taracads. – way to access: http://emedicine.medscape.com/article/115763823. Yamanaka R. Results of treatment of 112 cases of primary CNS lymphoma [Text] / R. Yamanaka, K. Morii, Y. Shinbo, et al. // Jpn. J. Clin. Oncol. – May 2008; 38 (5): 373–80.